TRANSMURAL SYSTEMS

We are passionate about understanding the impact our products have on our patients. 

Transmural Systems, established in 2013,  is a clinical stage medical device company.  We have a  platform of percutaneous structural heart therapies that is both complementary and innovative.  Our team brings years of combined implant medical device design, development, quality systems, manufacturing and commercialization experience.  The Transmural Systems team successfully advanced two of its products (Cerclage Mitral Annuloplasty and Transcaval Closure Device) from early-stage concept to FDA investigational device exemption (IDE) approval, and is successfully executing  early feasibility studies.